Cancer deaths expected to rise to over 18 million in 2050 – an increase of nearly 75%
There has been a rapid increase in the global number of cancer cases and deaths…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Severe obesity associated with reduced prevalence of recommended cancer screenings
In a recent cross-sectional study, researchers from Pennington Biomedical Research Centre, USA, found that severe…
Molecular roadmap links stomach infection to cancer risk
Gastric cancer remains one of the world’s leading causes of cancer deaths, yet the molecular…
Large language models enable multi-modality integration for brain tumour diagnosis and prognosis
Brain tumours, particularly gliomas, remain challenging to diagnose and treat. While radiology reports can offer…
Engineered gut bacteria improves survival outcomes in colorectal cancer tumours
In a new study that combines synthetic biology with cancer immunotherapy, researchers from the Yong…
New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers
A promising new PET tracer can visualise a protein that is commonly overexpressed in triple-negative…
Fish oil supplements may not work for certain cancer patients
About 19 million American adults consume dietary fish oil supplements. These supplements, which primarily consist…
Not all ALK fusions act the same: Variants influence treatment success in lung cancer
About five percent of lung adenocarcinomas, one of the most common forms of lung cancer,…
NBL1: A key driver of ovarian cancer metastasis
Ovarian cancer (OC), one of the three most common gynaecological malignancies, is characterised by low…
FDA approves pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous injection
On September 19, 2025, the Food and Drug Administration approved pembrolizumab and berahyaluronidase alfa-pmph for…